Dengue virus (DENV) that caused an outbreak in Dhaka, Bangladesh during 2018 was analysed phylogenetically. DENV samples were classified into type 2-Cosmopolitan genotype (54%) and type 3-genotype I (46%), indicating co-circulation of two DENV types and resurgence of type 3 associated with genotype replacement.
Dengue is a mosquito-borne disease caused by dengue virus (DENV) that is prevalent in urban areas in tropical and subtropical countries. Incidence of dengue has greatly increased in recent decades worldwide, causing an estimated 96 million symptomatic dengue cases per year. DENV, a member of the genus Flavivirus, family Flaviviridae, comprises four types (serotypes) that are further classified into genotypes. Prevalence of DENV types/genotypes differs depending on geographical regions, and changes occasionally. Increased incidence of dengue and severity of the disease have been associated with the change in circulating DENV types as well as virus evolution.
In Bangladesh, dengue has been an emerging public health concern since its resurgence in outbreaks from 2000 to 2002, caused mainly by DENV type 3 (DENV-3) [1, 2] . Thereafter, no serotype data were available until the period between 2013 and 2016, when DENV-1 and DENV-2 were reported as dominant serotypes [3] . In 2017, predominance of DENV-2 and reemergence of DENV-3 were observed [4] . In Dhaka, the capital of Bangladesh, an unprecedented large dengue outbreak has been occurring since August 2018, involving more than 10 000 dengue cases in that year, although between 400 and 6000 annual cases had been reported from 2008 to 2017 [5] . However, for the 2018 outbreak, the DENV type/genotype and its lineage have not been clarified.
During a period between September and November 2018, 90 serum samples were collected from individuals with suspected dengue in four tertiary-care hospitals in Dhaka presenting sudden onset of high fever of unknown origin (38.5°C, 7 days) with or without rash and joint pain. The presence of DENV protein/gene was tested by three methods: immunochromatography for NS1 antigen (Dengue NS1 Rapid Test Cassette, Acro Biotech Inc., Rancho Cucamonga, CA, USA), reverse transcription-polymerase chain reaction (RT-PCR), and quantitative PCR (qPCR) (RealStar dengue PCR kit 2.0, Altona Diagnostics, Hamburg, Germany). Detection rates of DENV were 71% (64/90), 70% (63/90) and 32% (29/90) by qPCR, immunochromatography and RT-PCR, respectively. Among all the samples tested, 73 were positive for DENV by any of the three methods, whereas 29 samples tested positive by all three methods. By RT-PCR targeting of the C-prM junction [6] , 511bp amplicons were obtained (see Supplementary material, Fig. S1 ). Among the 29 RT-PCR-positive samples, nucleotide sequences of the partial C-prM gene were determined for 24 samples, and deposited in GenBank under Accession nos MN400313-MN400336. DENV-positive rate was highest in the age group 20-29 years, followed by 30-39 years, and was higher in male than female patients (see Supplementary materials, Tables S1 and S2).
Phylogenetic analysis of the C-prM gene using the MEGA.7 software package revealed that DENV in the 24 samples belonged to type 2 (54%, 13/24) or type 3 (46%, 11/24). All the DENV-2 were assigned to Cosmopolitan genotype and were 
